GlassScriptPhysician profile
Jordan H Leff
NPI 1255312120
$495.22
in general payments reported to CMS, 2019-2025
12 companies · $32.31 in 2025
The $32.31 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60.17 · 2022: $127 · 2023: $186 · 2024: $89.97 · 2025: $32.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $129.49 | 2023-2024 | |
| Seqirus USA INC | $88.06 | 2021-2023 | Flucelvax Quadrivalent |
| Mayne Pharma Commercial LLC | $55.35 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $43.28 | 2022-2023 | Flumist Quadrivalent |
| Merck Sharp & Dohme LLC | $33.16 | 2022 | |
| Tris Pharma INC | $30.69 | 2022-2024 | Dyanavel Xr |
| Verrica Pharmaceuticals INC. | $23.94 | 2023 | Ycanth |
| Takeda Pharmaceuticals U.S.A., INC. | $22.82 | 2021 | |
| Supernus Pharmaceuticals, INC. | $20.32 | 2021 | |
| Alexion Pharmaceuticals, INC. | $18.53 | 2023 | Strensiq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.73 | 2022 | |
| Glaxosmithkline, LLC. | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Leff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.